Spots Global Cancer Trial Database for A Study of LY2523355 in Patients With Solid Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of LY2523355 in Patients With Solid Cancer
Official Title: A Phase 1 Study of LY2523355 in Patients With Solid Cancer
Study ID: NCT01358019
Conditions
Interventions
Study Description
Brief Summary: The primary objective of this study is to examine a recommended dose for subsequent phase trial(s), by the observation of the safety and toxicity profiles of LY2523355 in patients with advanced and/or metastatic cancer. The secondary objectives are to study the pharmacokinetics and antitumor effect.
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Tokyo, , Japan
Contact Details
Name: Senior Manager
Affiliation: Kyowa Kirin Co., Ltd.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
